OOIR: Observatory of International Research

Papers

(The TQCC of World Allergy Organization Journal is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee	121
Managing food allergy: GA2LEN guideline 2022	84
Air pollution and indoor settings	74
Allergy and immunology in young children of Japan: The JECS cohort	64
Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence	56
Relationship between blood eosinophil levels and COVID-19 mortality	52
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update	48
The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management	48
Update on latex allergy: New insights into an old problem	44
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions	39
A systematic review and meta-analysis of risk factors associated with atopic dermatitis in Asia	37
Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review	37
The Peanut Allergy Burden Study: Impact on the quality of life of patients and caregivers	36
Food labeling issues for severe food allergic patients	33
Enhancing innate immunity against virus in times of COVID-19: Trying to untangle facts from fictions	33
DRESS syndrome: A literature review and treatment algorithm	33
A systematic review of infant feeding food allergy prevention guidelines – can we AGREE?	33
Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement	26
Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases	25
Inborn errors of immunity with atopic phenotypes: A practical guide for allergists	25
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - III - Cow's milk allergens and mechanisms triggering immune activation	25
Current and emerging biologic therapies targeting eosinophilic disorders	25
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy	24
Incidence and timing of offspring asthma, wheeze, allergic rhinitis, atopic dermatitis, and food allergy and association with maternal history of asthma and allergic rhinitis	23
Severe asthma: One disease and multiple definitions	22

The US population-level burden of cow's milk allergy	22
Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both	22
An update on the prevalence, chronicity, and severity of atopic dermatitis and the associated epidemiological risk factors in the Singapore/Malaysia Chinese young adult population: A detailed descript	22
Biologics and global burden of asthma: A worldwide portrait and a call for action	21
Recent advances in the management of nut allergy	21
Variability of grass pollen allergy symptoms throughout the season: Comparing symptom data profiles from the Patient's Hayfever Diary from 2014 to 2016 in Vienna (Austria)	20
The rationale for development of ligelizumab in food allergy	19
The role of environmental allergen control in the management of asthma	18
Psychological impact of the COVID-19 pandemic on patients with allergic diseases	18
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital	18
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments	18
Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group	18
Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use	17
First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients	17
Risks and safety of biologics: A practical guide for allergists	17
Allergic diseases in infancy: I - Epidemiology and current interpretation	17
Economic burden of severe asthma treatment: A real-life study	17
WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)	17
Consensus on DEfinition of Food Allergy SEverity (DEFASE): Protocol for a systematic review	17
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update – VII – Milk elimination and reintroduction in the diagnostic process of cow's	17
Recent advances in diagnosing and managing nut allergies with focus on hazelnuts, walnuts, and cashew nuts	17
The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: A UCARE study	16
Prevalence of asthma and allergies among children in the United Arab Emirates: A cross-sectional study	16
Harmonizing allergy care–integrated care pathways and multidisciplinary approaches	16
Quick Olfactory Sniffin’ Sticks Test (Q-Sticks) for the detection of smell disorders in COVID-19 patients	16
The other side of the coin: IgE deficiency, a susceptibility factor for malignancy occurrence	16
Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)	15
Prevalence and risk factors of allergic rhinitis and asthma in the southern edge of the plateau grassland region of northern China: A cross-sectional study	15
Expert consensus on the use of omalizumab in chronic urticaria in China	15
Dupilumab: An emerging therapy in allergic fungal rhinosinusitis	15
An updated prevalence of asthma, its phenotypes, and the identification of the potential asthma risk factors among young Chinese adults recruited in Singapore	15
Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema	14
Pediatric usage of Omalizumab: A promising one	14
Food allergies and allergens: Characterization and perceptions among diagnosed food allergic individuals in Lebanon	13
A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics	13
Oral immunotherapy for food allergy: Translation from studies to clinical practice?	13
The prevalence and year lived with disability of atopic dermatitis in China: Findings from the global burden of disease study 2019	12
Allergenicity assessment and allergen profile analysis of different Chinese wheat cultivars	12
How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study	12
Epidemiology of adult patients with atopic dermatitis in AWARE 1: A second international survey	12
Hydrolyzed rice formula for dietary management of infants with cow's milk allergy	12
Allergic rhinitis in Chinese young adults from the Singapore/Malaysia cross-sectional genetics epidemiology study (SMCGES) cohort: Prevalence, patterns, and epidemiology of allergic rhinitis	12
Latin American anaphylaxis registry	12
Algorithm to guide re-exposure to penicillin in allergic pregnant women with syphilis: Efficacy and safety	12
Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases	12
Rapid transition to home omalizumab treatment for chronic spontaneous urticaria during the COVID-19 pandemic: A patient perspective	12
Effect of environmental exposures on allergen sensitization and the development of childhood allergic diseases: A large-scale population-based study	12
Allergic rhinitis aggravated by air pollutants in Latin America: A systematic review	12
Long-term effectiveness and safety of omalizumab in pediatric and adult patients with moderate-to-severe inadequately controlled allergic asthma	12
Utility of biomarkers in the diagnosis and monitoring of asthmatic children	12

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life	12
Digital tools in allergy and respiratory care	11
Prevalence of asthma symptoms and associated risk factors among adults in Saudi Arabia: A national survey from Global Asthma Network Phase Ⅰ	11
Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor	11
Assessment of perception, attitude, and practice of primary care practitioners towards allergic rhinitis practice guidelines: Development and validation of a new questionnaire	11
Allergic manifestations of inborn errors of immunity and their impact on the diagnosis: A worldwide study	11
Urban vs rural – Prevalence of self-reported allergies in various occupational and regional settings	11
Prevalence and risk factors associated with allergic rhinitis in Mexican school children: Global Asthma Network Phase I	11
Knowledge of healthcare providers in the management of anaphylaxis	11
Severity of COVID-19 in hospitalized patients with and without atopic disease	11
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XIII – Oral immunotherapy for CMA – Systematic review	11
Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)	11
Prenatal vitamin D supplementation and child respiratory health: A systematic review and meta-analysis of randomized controlled trials	11
Association of infant antibiotic exposure and risk of childhood asthma: A meta-analysis	10
Predicting allergic diseases in children using genome-wide association study (GWAS) data and family history	10
The disease burden and quality of life of chronic cough patients in South Korea and Taiwan	10
Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy	10
Lipid transfer protein syndrome: How to save a life through careful education	10
Naso-ocular neuropeptide interactions in allergic rhinoconjunctivitis, rhinitis, and conjunctivitis	10
Bronchodilator response and lung function decline: Associations with exhaled nitric oxide with regard to sex and smoking status	10
Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong – Clinical outcomes, barriers to vaccination, and urgency for reform	10
The prevalence and temporal trends of food allergy among preschool children in Northern Thailand between 2010 and 2019	10
WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19	9
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update – X – Breastfeeding a baby with cow's milk allergy	9
Atopic dermatitis in the COVID-19 era: Results from a web-based survey	9
Unanswered questions on the use of biologics in pediatric asthma	9
Meaningful changes for efficacy outcomes in patients with chronic rhinosinusitis with nasal polyps	9
WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways	9
Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers – A real-life	9
Variability of Type 2 inflammatory markers guiding biologic therapy of severe asthma: A 5-year retrospective study from a single tertiary hospital	9
Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting S	9
Age-related differences in characteristics of anaphylaxis in Chinese children from infancy to adolescence	9
The changes of clinical and histological characteristics of chronic rhinosinusitis in 18 years: Was there an inflammatory pattern shift in southern China?	9
Microbiome profiling of nasal extracellular vesicles in patients with allergic rhinitis	9
Erratum to "IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper" [World Allergy Organ J 13/2 (2020) 100080]	8
Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis	8
Association of asthma comorbidity with poor prognosis of coronavirus disease 2019	8
Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps	8
Epidemiologic features and burden of atopic dermatitis in adolescent and adult patients: A cross-sectional multicenter study	8
WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates in COVID-19	8
Negative impact of penicillin allergy labels on antibiotic use in hospitalized patients in Chinese Mainland	8
Pollen respiratory allergy: Is it really seasonal?	8
Linking cross-reactivity clusters of food and respiratory allergens in PAMD@ to asthma and duration of allergy	8
Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic	8
The efficacy of a novel smart watch on medicine adherence and symptom control of allergic rhinitis patients: Pilot study	8
75% negative skin test results in patients with suspected hypersensitivity to beta-lactam antibiotics: Influencing factors and interpretation of test results	8
Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis	7
Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection	7
PEG allergy — A COVID-19 pandemic-made problem? A German perspective	7
Decreasing ten-year (2008–2018) trends of the prevalence of childhood asthma and air pollution in Southern Taiwan	7
Dyslipidemia among allergic rhinitis patients: Frequency and risk factors	7
High occurrence of simultaneous multiple-drug hypersensitivity syndrome induced by first-line anti-tuberculosis drugs	7
Prevalence and risk factors of allergic rhinitis among Chinese adults: A nationwide representative cross-sectional study	7
Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU)☆	7
Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023	7
Increasing anaphylaxis events in Western Australia identified using four linked administrative datasets	7
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines update – VI – A quality appraisal with the AGREE II instrument	7
Identifying gene network patterns and associated cellular immune responses in children with or without nut allergy	7
Active smoking effect in allergic rhinitis	7
Naples prognostic score as a novel prognostic prediction indicator in adult asthma patients: A population-based study	7
Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions	7
Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology – ASBAI	7
IgE, blood eosinophils and FeNO are not enough for choosing a monoclonal therapy among the approved options in patients with type 2 severe asthma	7
Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic	7
Component-resolved diagnosis in adult patients with food-dependent anaphylaxis	7
Prospective analysis of clinical evolution in chronic urticaria: Persistence, remission, recurrence, and pruritus alone	7
CircRNA expression profiles and circRNA-miRNA-mRNA crosstalk in allergic rhinitis	7
Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – Results from t	7
Smoking behavior might affect allergic rhinitis and vasomotor rhinitis differently: A mendelian randomization appraisal	7
Prevalence of self-reported food allergy among adults in Jiangxi, China	7
A systematic review of quality and consistency of clinical practice guidelines on the primary prevention of food allergy and atopic dermatitis	7
The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations	7
Environmental contributions to the interactions of COVID-19 and asthma: A secondary publication and update	7
Multi-omics profiling approach in food allergy	7